Be sure to schedule Saturday, June 6th, on your calendar! We’re meeting from 1:00-3:00 p.m. in New Britain ..and we’re excited to announce that staff from Praxis Precision Medicines will be our speakers!

Praxis was granted FDA’s Breakthrough Therapy Designation based on the positive topline results from the Essential3 Phase 3 program in essential tremor in creating the first ET-specific drug and was encouraged to submit an NDA (new drug application) to the FDA!

Details to follow..